Cardiac Glycoside
42 drugs across 14 manufacturers|39 Generic,3 Brand
The Cardiac Glycoside class contains 42 NDCs from 14 manufacturers (39 generic, 3 brand), at an average NADAC of $1.45 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
42
39G / 3B
Manufacturers
14
Avg $1.4517/unit
Avg 7d Change
-1.45%
Across 30 drugs with changes
7d Activity
of 42 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
14 manufacturers producing drugs in this therapeutic class(1 pricing outlier)
and 2 more manufacturers
Follow this class across the site
These links connect the therapeutic class page to the specific suppliers, markets, and trend surfaces that help users keep exploring.
Top supplier
Aurobindo Pharma Limited manufacturer profile
Review the supplier with the strongest product footprint inside this therapeutic class.
Lead market
Digoxin market page
Move from the therapeutic class into the molecule that appears most often in this class-specific portfolio.
Trend hub
Latest trend hub
Compare this class against the rest of the weekly NADAC trend surface.
Guide
Understanding NADAC pricing
Use the explainer when you need a plain-English refresher on how these class-level numbers are published and interpreted.
Frequently Asked Questions
How many drugs are in the Cardiac Glycoside class?
The Cardiac Glycoside class contains 42 NDCs from 14 manufacturers — 39 generic and 3 brand products.
What is the average price of Cardiac Glycoside drugs?
The average NADAC for the Cardiac Glycoside class is $1.4517 per unit across 42 NDCs.
Is generic cheaper than brand in the Cardiac Glycoside class?
Among products priced per EA, the average generic NADAC in this class is $0.6290, versus $11.6289 for brand — brand products average about 18× the generic price.
Which manufacturers make Cardiac Glycoside drugs?
14 manufacturers make drugs in the Cardiac Glycoside class. Ranked by number of NDCs, the largest are Aurobindo Pharma Limited (5), ANI Pharmaceuticals, Inc. (5), Hikma Pharmaceuticals USA Inc. (5), Amneal Pharmaceuticals of New York LLC (4), Sun Pharmaceutical Industries Inc. (4).
How has Cardiac Glycoside pricing changed recently?
Over the past 7 days, 18 NDCs in this class rose and 12 fell, with a class-wide average change of -1.4%.